Article Versions Notes

Palicelli A, Croci S, Bisagni A, Zanetti E, De Biase D, Melli B, Sanguedolce F, Ragazzi M, Zanelli M, Chaux A, et al. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models). International Journal of Molecular Sciences. 2021; 22(22):12297. https://doi.org/10.3390/ijms222212297

Palicelli, Andrea, Stefania Croci, Alessandra Bisagni, Eleonora Zanetti, Dario De Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Magda Zanelli, Alcides Chaux, and et al. 2021. "What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models)" International Journal of Molecular Sciences 22, no. 22: 12297. https://doi.org/10.3390/ijms222212297

Palicelli, A., Croci, S., Bisagni, A., Zanetti, E., De Biase, D., Melli, B., Sanguedolce, F., Ragazzi, M., Zanelli, M., Chaux, A., Cañete-Portillo, S., Bonasoni, M. P., Soriano, A., Ascani, S., Zizzo, M., Castro Ruiz, C., De Leo, A., Giordano, G., Landriscina, M., ... Bonacini, M. (2021). What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models). International Journal of Molecular Sciences, 22(22), 12297. https://doi.org/10.3390/ijms222212297